Inventor
CHARNEAU PIERRE
FR36 patents
⚠️ This page may combine multiple inventors who share the name “CHARNEAU PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
21 patentsUS6682907B1Jan 27, 2004
Use of triplex structure DNA in transferring nucleotide sequences
PASTEUR INSTITUT198 citations98
US6103462AAug 15, 2000
Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
PASTEUR INSTITUT56 citations95
US7981671B2Jul 19, 2011
Use of triplex structure DNA in transferring nucleotide sequences
PASTEUR INSTITUT12 citations92
US7968332B2Jun 28, 2011
Lentiviral vectors for the preparation of immunotherapeutical compositions
PASTEUR INSTITUT16 citations92
US6399294B1Jun 4, 2002
Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
PASTEUR INSTITUT17 citations90
US10407695B2Sep 10, 2019
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
PASTEUR INSTITUT13 citations89
US8343718B2Jan 1, 2013
Strain of SARS-associated coronavirus and applications thereof
PASTEUR INSTITUT22 citations87
US7736850B2Jun 15, 2010
Strain of SARS-associated coronavirus and applications thereof
PASTEUR INSTITUT18 citations87
US8367068B2Feb 5, 2013
Use of triplex structure DNA in transferring nucleotide sequences
PASTEUR INSTITUT5 citations83
US8349606B2Jan 8, 2013
Lentiviral vectors for the preparation of immunotherapeutical compositions
PASTEUR INSTITUT10 citations83
US7157225B2Jan 2, 2007
Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
PASTEUR INSTITUT10 citations81
US8652807B2Feb 18, 2014
Lentiviral vectors for the preparation of immunotherapeutical compositions
PASTEUR INSTITUT4 citations79
US9328146B2May 3, 2016
Lentiviral gene transfer vectors and their medicinal applications
PASTEUR INSTITUT2 citations59
US9238824B2Jan 19, 2016
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
PASTEUR INSTITUT2 citations59
US11779640B2Oct 10, 2023
Lentiviral vector-based Japanese encephalitis immunogenic composition
PASTEUR INSTITUT0 citations57
US9442114B2Sep 13, 2016
Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
PASTEUR INSTITUT2 citations55
US6558923B2May 6, 2003
Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance
PASTEUR INSTITUT3 citations54
US9499799B2Nov 22, 2016
Cells and methodology to generate non-segmented negative-strand RNA viruses
PASTEUR INSTITUT0 citations51
US12521428B2Jan 13, 2026
Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
PASTEUR INSTITUT0 citations49
US10603374B2Mar 31, 2020
Lentiviral vector-based Japanese encephalitis immunogenic composition
PASTEUR INSTITUT0 citations46
US11369670B2Jun 28, 2022
Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host
PASTEUR INSTITUT0 citations42
CHARNEAU PIERRE
12 patentsUS8420104B2Apr 16, 2013
Lentiviral gene transfer vectors and their medicinal applications
CHARNEAU PIERRE43 citations94
US8709799B2Apr 29, 2014
Lentiviral gene transfer vectors and their medicinal applications
CHARNEAU PIERRE27 citations89
US8093042B2Jan 10, 2012
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
CHARNEAU PIERRE26 citations89
US8460678B2Jun 11, 2013
Use of triplex structure DNA in transferring nucleotide sequences
CHARNEAU PIERRE5 citations83
US8450087B2May 28, 2013
Use of triplex structure DNA in transferring nucleotide sequences
CHARNEAU PIERRE4 citations73
US8512993B2Aug 20, 2013
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
CHARNEAU PIERRE4 citations70
US8512994B2Aug 20, 2013
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
CHARNEAU PIERRE3 citations59
US8236324B2Aug 7, 2012
Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens
CHARNEAU PIERRE2 citations59
US8222029B2Jul 17, 2012
Lentiviral vector-based vaccine
CHARNEAU PIERRE1 citations52
US8158413B2Apr 17, 2012
Lentiviral vector-based vaccine
CHARNEAU PIERRE1 citations52
US9822153B2Nov 21, 2017
Lentiviral vector based immunological compounds against malaria
CHARNEAU PIERRE0 citations50
US9109234B2Aug 18, 2015
Lentiviral vector based immunological compounds against malaria
CHARNEAU PIERRE0 citations50